Search

everythinglearnresearchcommunity

for

Search:↓

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Antiandrogens block male hormones and are not safe during pregnancy.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Bicalutamide may help treat female pattern hair loss.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.